Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Leap Therapeutics Inc (LPTX)

Leap Therapeutics Inc (LPTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 105,372
  • Shares Outstanding, K 56,049
  • Annual Sales, $ 0 K
  • Annual Income, $ -32,900 K
  • 60-Month Beta 1.89
  • Price/Sales 128.75
  • Price/Cash Flow N/A
  • Price/Book 3.93

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.17
  • Number of Estimates 4
  • High Estimate -0.11
  • Low Estimate -0.25
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +54.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7500 +7.43%
on 07/20/20
2.2700 -17.18%
on 07/21/20
-0.1200 (-6.00%)
since 07/07/20
3-Month
1.7500 +7.43%
on 07/20/20
3.0200 -37.75%
on 06/02/20
-0.3100 (-14.16%)
since 05/07/20
52-Week
0.5728 +228.21%
on 11/14/19
3.1800 -40.88%
on 02/19/20
+0.3400 (+22.08%)
since 08/07/19

Most Recent Stories

More News
Leap Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

, /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the closing of an additional 3,375,000...

LPTX : 1.8800 (-4.57%)
Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants

, Mass., /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the closing of a public offering...

LPTX : 1.8800 (-4.57%)
Leap Therapeutics Announces Pricing of $45 Million of Common Stock and Pre-Funded Warrants

, /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the pricing of an underwritten public...

LPTX : 1.8800 (-4.57%)
Leap Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

, /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has commenced an underwritten...

LPTX : 1.8800 (-4.57%)
Company News for Jun 15, 2020

Companies in the news are: EMAN, LPTX, VISL, CLPS

EMAN : 1.3200 (-8.97%)
LPTX : 1.8800 (-4.57%)
CLPS : 2.49 (-0.80%)
VISL : 2.49 (-6.04%)
Leap Therapeutics (LPTX) Soars: Stock Adds 8.3% in Session

Leap Therapeutics (LPTX) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

LPTX : 1.8800 (-4.57%)
ARPO : 1.5900 (+11.97%)
Leap Therapeutics Announces Oprhan Drug Designation of DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer

, /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that the U.S. Food and Drug Administration...

LPTX : 1.8800 (-4.57%)
Leap Therapeutics Announces Changes to Virtual Format and Time for 2020 Annual Meeting of Stockholders

, /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that, due to public health and safety...

LPTX : 1.8800 (-4.57%)
Leap Therapeutics Reports First Quarter 2020 Financial Results

, /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the first quarter...

LPTX : 1.8800 (-4.57%)
Leap Therapeutics to Present Updated Data for DKN-01 Monotherapy and Paclitaxel Combination In Gynecologic Cancers

Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced updated clinical data from its ongoing Phase 2 clinical...

LPTX : 1.8800 (-4.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade LPTX with:

Business Summary

Leap Therapeutics, Inc. is a biopharmaceutical company. It develops novel therapeutics for the treatment of cancer. Leap Therapeutics, Inc. is based in Cambridge, United States.

See More

Key Turning Points

2nd Resistance Point 2.0800
1st Resistance Point 1.9800
Last Price 1.8800
1st Support Level 1.8300
2nd Support Level 1.7800

See More

52-Week High 3.1800
Fibonacci 61.8% 2.1840
Last Price 1.8800
Fibonacci 50% 1.8764
Fibonacci 38.2% 1.5688
52-Week Low 0.5728

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar